Euclid Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Euclid Pharmaceuticals
Euclid Pharmaceuticals Limited (EPL) is a Public Limited Indian Non-Government Company incorporated in India on 14 November 1990 and has a history of 34 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Lata Jain, Varsha Jain, and Shantilal Jain serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U17120MH1990PLC058963
- Company No.
058963
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Nov 1990
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Euclid Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lata Jain  | Director | 05-Feb-2016 | Current |
| Varsha Jain | Director | 28-Sep-2005 | Current |
| Shantilal Jain | Director | 28-Sep-2005 | Current |
Financial Performance of Euclid Pharmaceuticals.
Euclid Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Euclid Pharmaceuticals?
In 2017, Euclid Pharmaceuticals had a promoter holding of 49.20% and a public holding of 50.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Varsha Ventures LimitedLata Jain and Varsha Jain are mutual person
Varsha Construction LimitedLata Jain and Varsha Jain are mutual person
Varsha Commodities LimitedLata Jain and Shantilal Jain are mutual person
India Gold LimitedShantilal Jain is a mutual person
Varsha Mines And Granites LtdLata Jain, Varsha Jain and 1 more are mutual person
- Varsha Technologies Limited
Lata Jain and Shantilal Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Euclid Pharmaceuticals?
Unlock and access historical data on people associated with Euclid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euclid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euclid Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
